Side-by-side comparison of AI visibility scores, market position, and capabilities
Avise provides specialized diagnostic tests for autoimmune diseases including lupus and rheumatoid arthritis that help rheumatologists make faster and more accurate diagnoses.
Avise Medical is a specialty diagnostics company founded in 2012 that develops laboratory tests specifically designed to help rheumatologists diagnose and monitor autoimmune diseases including lupus, rheumatoid arthritis, and related conditions. The company's flagship products include AVISE Lupus, a panel of blood biomarkers that increases diagnostic accuracy for systemic lupus erythematosus compared to traditional single-marker tests, and AVISE CTD for connective tissue disease diagnosis. Autoimmune diseases are notoriously difficult to diagnose because symptoms overlap with many other conditions and individual biomarkers have limited sensitivity and specificity. Avise addresses this through multi-biomarker panels that use machine learning to combine signals into diagnostic scores with better performance characteristics. The company works directly with rheumatology practices and provides specialized clinical interpretation support for complex cases. Avise raised over $100M and expanded its diagnostic portfolio to cover monitoring of disease activity and treatment response in addition to initial diagnosis. The company represents the application of advanced biomarker discovery and machine learning to specialty diagnostics in rheumatology.
Indoor vertical farming company using AI-optimized growing systems. San Francisco, CA. Raised $940M+ including $400M from SoftBank. Partners with Walmart for US farms.
Plenty is a San Francisco-based indoor vertical farming company that uses AI, machine learning, and robotics to grow leafy greens and other produce in controlled indoor environments. The company has raised over $940 million from investors including SoftBank Vision Fund, which invested $200 million in 2017, and has positioned itself as the technology leader in data-driven indoor agriculture.\n\nPlenty's farms use precisely controlled light, temperature, humidity, and nutrient conditions to grow crops that are free from pesticides, use 99% less land, and consume significantly less water than conventional field agriculture. The company's AI systems continuously optimize growing conditions based on sensor data, learning to improve yields and quality across crops and growing cycles.\n\nIn 2022, Plenty announced a landmark partnership with Walmart to supply leafy greens from a new large-scale facility in Compton, California. This partnership provided both a major commercial anchor and significant additional funding from Walmart, validating Plenty's technology and business model at scale. The company also operates a dedicated strawberry R&D partnership with Driscoll's, the world's largest berry company, demonstrating the platform's potential beyond leafy greens.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.